优化对药物的坚持,以改善喘的结果
Pamela Rackow1, Amelia Drennan1, Hilary Pinnock2
1University of Stirling, Faculty of Natural Sciences, Psychology, Stirling.
Current opinion in pulmonary medicine
|March 19, 2025
概括
改善喘治疗药物坚持需要个性化干预措施,解决个人障碍,并利用数字工具来改善患者与提供者之间的沟通. 包括心理健康在内的整体管理是最佳控制喘和减少恶化症的关键.
科学领域:
- 肺部病理学 肺部病理学
- 行为科学 行为科学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药物坚持对于有效的喘管理和预防恶化至关重要.
- 最近的研究重点是了解坚持障碍和开发有针对性的干预措施.
- 本综述综合了喘坚持研究当前的进展,以实际应用.
研究的目的:
- 审查最近喘药物坚持研究的进展.
- 突出这些进展在临床实践中的潜力.
- 识别关键决定因素和有效的干预策略,以改善遵守.
主要方法:
- 对最近关于喘药物坚持性的研究进行文献综述.
- 分析影响遵守的因素 (个人,社会,医疗服务相关).
- 数字技术的评估和定制的干预措施,以支持坚持.
主要成果:
- 坚持受到个人因素,社会背景和医疗服务提供的影响.
- 量身定制的干预措施,简短的障碍评估和基于证据的策略是有效的.
- 像智能吸入器和远程医疗等数字技术显示出希望,但面临实施挑战.
- 整合心理健康支持和单一地点的护理可以提高坚持和结果.
结论:
- 整体性喘管理应纳入心理健康方面的考虑.
- 根据个人需求量身定制的个性化坚持干预措施是可行的和有效的.
- 数字健康解决方案为改善喘护理提供了潜力,但需要持续的实施策略.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
201
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
201
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
COPD: Management Using Bronchodilators and Corticosteroids
166
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
166
Inhaled Medications
210
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
210
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


